Cargando…
EMMPRIN/CD147 is a novel coreceptor of VEGFR-2 mediating its activation by VEGF
EMMPRIN/CD147 is mainly known for its protease inducing function but a role in promoting tumor angiogenesis has also been demonstrated. This study provides evidence that EMMPRIN is a new coreceptor for the VEGFR-2 tyrosine kinase receptor in both endothelial and tumor cells, as it directly interacts...
Autores principales: | Khayati, Farah, Pérez-Cano, Laura, Maouche, Kamel, Sadoux, Aurélie, Boutalbi, Zineb, Podgorniak, Marie-Pierre, Maskos, Uwe, Setterblad, Niclas, Janin, Anne, Calvo, Fabien, Lebbé, Céleste, Menashi, Suzanne, Fernandez-Recio, Juan, Mourah, Samia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496396/ https://www.ncbi.nlm.nih.gov/pubmed/25825981 |
Ejemplares similares
-
EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression
por: Lescaille, Géraldine, et al.
Publicado: (2012) -
CD147 Promotes Tumor Lymphangiogenesis in Melanoma via PROX-1
por: Reger de Moura, Coralie, et al.
Publicado: (2021) -
EMMPRIN Promotes Melanoma Cells Malignant Properties through a HIF-2alpha Mediated Up-Regulation of VEGF-Receptor-2
por: Bougatef, Faten, et al.
Publicado: (2010) -
A novel tumor suppressor function of Kindlin-3 in solid cancer
por: Djaafri, Ibtissem, et al.
Publicado: (2014) -
A Reliable Method for the Selection of Exploitable Melanoma Archival Paraffin Embedded Tissues for Transcript Biomarker Profiling
por: Lebbe, Celeste, et al.
Publicado: (2012)